Feedback PLC Notice of Results & Investor Presentation
06 Febbraio 2024 - 8:00AM
RNS Regulatory News
RNS Number : 0351C
Feedback PLC
06 February 2024
Feedback plc
Notice of Results & Investor
Presentation
Feedback plc (AIM: FDBK, "Feedback"
or the "Company"), the specialist clinical technology company, will
announce results for the half year ended 30 November 2023 on
Wednesday 21 February 2024.
Analyst Presentation: 09:30, Wednesday 21
February
A remote briefing for analysts will
be held at 09:30 on the morning of the results. Analysts
interested in attending should contact Walbrook PR
on feedbackplc@walbrookpr.com or 020 7933
8780.
Investor Presentation: 16:00, Wednesday 21
February
Management will be providing a
presentation and hosting an investor Q&A session on the
Company's results and future prospects on Wednesday 21 February at
16:00. Investors can sign up for free and register to meet FDBK via
the following link:
https://www.investormeetcompany.com/feedback-plc/register-investor
Investors who have already registered
on the Investor Meet Company platform to meet the Company will
automatically be invited.
-Ends-
Enquiries:
Feedback plc
Tom Oakley, CEO
Anesh Patel, CFO
|
+44 (0) 20 3997 7634
IR@fbk.com
|
|
|
Panmure Gordon (UK) Limited (NOMAD and
Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate
Broking)
|
+44 (0)20 7886 2500
|
|
|
Walbrook PR Ltd;
|
Tel: 020 7933 8780 or
feedbackplc@walbrookpr.com
|
Nick Rome/Joe Walker
|
07748 325 236 or 07407 020
470
|
About Feedback
Feedback plc helps clinical teams to
make better decisions faster for patients. We design products that
enhance clinician access to patient data and to their colleagues.
Our unique approach centres around individual patient episodes,
into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a
result, we produce a digital infrastructure that makes patient data
available to clinicians in multiple settings, in a format that
enables them to meaningfully interact with it, providing
flexibility to clinicians and free movement of patients between
provider settings - clinicians can practice from anywhere and
patients can attend any care provider for
treatment.
Our products Bleepa and CareLocker
work together to deliver unparalleled value to our customers.
Bleepa is our application layer and sits on top of CareLocker as
our data layer. Bleepa is a clinician facing platform that displays
clinical results from a patient's CareLocker at a certified and
regulated quality, that is suitable for clinical use and enables
dialogue on a patient-by-patient basis with colleagues through a
secure, auditable chat interface that links back to the patient
medical record. The CareLocker data storage model is built around
the patient. Our vision is one where relevant clinical data is
always available to the patient as well as to any care setting that
they may attend - a federated data architecture with the patient as
the tenant.
The Company has a number of growth
opportunities domestically and internationally across a range of
markets including the NHS and private healthcare providers and its
highly scalable Software as a Service ("SaaS")-based model is
expected to provide increasing levels of revenue visibility as the
Company grows its customer base.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NORSSMFSIELSEFE
Grafico Azioni Feedback (LSE:FDBK)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Feedback (LSE:FDBK)
Storico
Da Mar 2024 a Mar 2025